The current price of REGN is $902.90 — it has decreased by 2.98% since the previous close. Data as of Nov 5, 2026.
REGN is up 3.85% over the past week, up 24.29% over the past month and up 40.16% over the past year. The price is above its 200-day moving average of $740.82.
Analysts' average 12-month price target for REGN is $887.79, which implies 1.67% downside from the current price. Individual estimates range from $756.00 to $1,100.00.
Of the 29 analysts covering Regeneron Pharmaceuticals, Inc., 4 rate it a strong buy, 15 rate it a buy, 9 rate it a hold and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Regeneron Pharmaceuticals, Inc. has a market capitalization of $93.39B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Regeneron Pharmaceuticals, Inc. posted earnings of $20.07 per share against an estimate of $16.51, beating expectations by 21.56%. Upcoming reports are listed in the earnings calendar.
Regeneron Pharmaceuticals, Inc. reported revenue of $5.12B in its most recent quarter, which has increased by 36.27% compared with the same quarter a year earlier. Analysts had expected $4.58B.
Yes. Regeneron Pharmaceuticals, Inc. pays dividends quarterly. The latest payment of $0.94 per share has a payment date of Dec 3, 2026, which corresponds to a dividend yield of 0.42%.
Companies most comparable to Regeneron Pharmaceuticals, Inc. include Novartis AG, AstraZeneca PLC, Amgen Inc., Gilead Sciences, Inc. and Biogen Inc.
In the latest trading session REGN moved between $901.61 and $948.06, a range of 5.14% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Regeneron Pharmaceuticals, Inc. shows a buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks REGN has traded between $591.52 and $991.73. The current price is 8.96% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.